Literature DB >> 8325052

Disseminated Strongyloides stercoralis in human immunodeficiency virus-infected patients. Treatment failure and a review of the literature.

K D Lessnau1, S Can, W Talavera.   

Abstract

We describe a North American human immunodeficiency virus (HIV)-positive patient with Strongyloides stercoralis infection of the gastrointestinal tract, who required repeated "standard" courses of thiabendazole. Pulmonary infection with numerous roundworms developed, as suspected by bronchoalveolar lavage, and while he was receiving therapy, dissemination occurred. On autopsy, S stercoralis was recovered in the gastrointestinal tract, liver, lung, and heart. After a literature review, we conclude that HIV-positive patients have a higher risk of dissemination and "standard" treatment failure. This may occur without elevation of IgE or eosinophilia. Those patients may require prolonged courses of thiabendazole or alternatively ivermectin therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325052     DOI: 10.1378/chest.104.1.119

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  Disseminated strongyloidiasis: a retrospective study of clinical course and outcome.

Authors:  C S Lam; M K H Tong; K M Chan; Y P Siu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

2.  Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis.

Authors:  Ashley M Newberry; David N Williams; William M Stauffer; David R Boulware; Brett R Hendel-Paterson; Patricia F Walker
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

3.  Pulmonary strongyloidiasis presenting micronodules on chest computed tomography.

Authors:  Kyungsoo Bae; Kyung Nyeo Jeon; Ji Young Ha; Jong Sil Lee; Byoung-Kuk Na
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

4.  Pulmonary Strongyloidiasis: The Varied Clinical Presentations.

Authors:  Babak Mokhlesi; Oksana Shulzhenko; Prasad S Garimella; Leslie Kuma; Catherine Monti
Journal:  Clin Pulm Med       Date:  2004-01

5.  Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.

Authors:  M Satoh; H Toma; Y Sato; M Takara; Y Shiroma; S Kiyuna; K Hirayama
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

Review 6.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  Parasitic disease screening among HIV patients from endemic countries in a Toronto clinic.

Authors:  Cecilia T Costiniuk; Curtis L Cooper; Steve Doucette; Colin M Kovacs
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

8.  Cryptosporidium and Strongyloides stercoralis infections among people with and without HIV infection and efficiency of diagnostic methods for Strongyloides in Yirgalem Hospital, southern Ethiopia.

Authors:  Amde Getaneh; Girmay Medhin; Techalew Shimelis
Journal:  BMC Res Notes       Date:  2010-04-01

Review 9.  Strongyloides stercoralis in the Immunocompromised Population.

Authors:  Paul B Keiser; Thomas B Nutman
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

10.  Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1.

Authors:  M Satoh; S Kiyuna; Y Shiroma; H Toma; A Kokaze; Y Sato
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.